LBA
REPL icon

Letko, Brosseau & Associates’s Replimune Group REPL Stock Holding History

Letko, Brosseau & Associates’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,800
Closed -$82.6K – 115
2026
Q1 		$82.6K Hold
10,800
– – ﹤0.01% 97
2025
Q4 		$105K Hold
10,800
– – ﹤0.01% 96
2025
Q3 		$45.3K Hold
10,800
– – ﹤0.01% 97
2025
Q2 		$100K Buy
+10,800
New +$94.2K ﹤0.01% 91
2023
Q1 		– Sell
-7,525
Closed -$205K – 95
2022
Q4 		$205K Sell
7,525
-15,275
-67% -$317K ﹤0.01% 93
2022
Q3 		$394K Hold
22,800
– – 0.01% 87
2022
Q2 		$399K Hold
22,800
– – 0.01% 87
2022
Q1 		$387K Hold
22,800
– – 0.01% 91
2021
Q4 		$618K Hold
22,800
– – 0.01% 92
2021
Q3 		$676K Hold
22,800
– – 0.01% 91
2021
Q2 		$876K Hold
22,800
– – 0.01% 92
2021
Q1 		$696K Hold
22,800
– – 0.01% 90
2020
Q4 		$870K Sell
22,800
-19,600
-46% -$817K 0.01% 94
2020
Q3 		$976K Buy
+42,400
New +$966K 0.02% 83

Other funds holding REPL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
RCI
Ridgeback Capital Investments Miami Beach, Florida $80.9M AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return

Letko, Brosseau & Associates's REPL Position: Q2 2026 in Review

Letko, Brosseau & Associates sold out of Replimune Group (REPL) in Q2 2026, closing a stake of 10,800 shares — an estimated $82.6K sold.

Letko, Brosseau & Associates first reported a position in REPL in Q3 2020 and held it in 14 quarters. The position peaked at $976K in Q3 2020. 199 funds tracked by Wall St. Rank hold REPL as of Q2 2026.

  • Letko, Brosseau & Associates reported no remaining Replimune Group position as of Q2 2026 after selling out during the quarter.
  • Letko, Brosseau & Associates sold 10,800 Replimune Group shares in Q2 2026, an estimated $82.6K.
  • Letko, Brosseau & Associates first reported a position in Replimune Group in Q3 2020 and held it in 14 quarters.
  • Letko, Brosseau & Associates's Replimune Group position peaked at $976K in Q3 2020.
  • 199 funds tracked by Wall St. Rank held Replimune Group as of Q2 2026.

Based on Letko, Brosseau & Associates's 13F filing for Q2 2026, filed 13 Aug 2026.